Reglodi D - Search Results

1

Early Neurobehavioral Development of Mice Lacking Endogenous PACAP.

Farkas J, Sandor B, Tamas A, Kiss P, Hashimoto H, Nagy AD, Fulop BD, Juhasz T, Manavalan S, Reglodi D. Farkas J, et al. Among authors: reglodi d. J Mol Neurosci. 2017 Apr;61(4):468-478. doi: 10.1007/s12031-017-0887-z. Epub 2017 Feb 6. J Mol Neurosci. 2017. PMID: 28168413

2

Pituitary adenylate cyclase activating polypeptide is highly abundant in the nervous system of anoxia-tolerant turtle, Pseudemys scripta elegans.

Reglödi D, Somogyvári-Vigh A, Vígh J, Li M, Lengvári I, Arimura A. Reglödi D, et al. Peptides. 2001 Jun;22(6):873-8. doi: 10.1016/s0196-9781(01)00412-0. Peptides. 2001. PMID: 11390016

3

Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.

Tamás A, Reglõdi D, Szántó Z, Borsiczky B, Németh J, Lengvári I. Tamás A, et al. Among authors: reglodi d. Neuro Endocrinol Lett. 2002 Jun;23(3):249-54. Neuro Endocrinol Lett. 2002. PMID: 12080287

4

Comparative distribution of VIP in the central nervous system of various species measured by a new radioimmunoassay.

Németh J, Jakab B, Reglodi D, Lubics A, Józsa R, Hollósy T, Tamás A, Lengvári I, Görcs T, Szolcsányi J. Németh J, et al. Among authors: reglodi d. Regul Pept. 2002 Nov 15;109(1-3):3-7. doi: 10.1016/s0167-0115(02)00165-9. Regul Pept. 2002. PMID: 12409208

5

Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.

Reglodi D, Tamás A, Somogyvári-Vigh A, Szántó Z, Kertes E, Lénárd L, Arimura A, Lengvári I. Reglodi D, et al. Peptides. 2002 Dec;23(12):2227-34. doi: 10.1016/s0196-9781(02)00262-0. Peptides. 2002. PMID: 12535703

6

Examination of sensorimotor performance following middle cerebral artery occlusion in rats.

Reglodi D, Tamás A, Lengvári I. Reglodi D, et al. Brain Res Bull. 2003 Feb 15;59(6):459-66. doi: 10.1016/s0361-9230(02)00962-0. Brain Res Bull. 2003. PMID: 12576143

7

The effects of PACAP and PACAP antagonist on the neurobehavioral development of newborn rats.

Reglodi D, Kiss P, Tamás A, Lengvári I. Reglodi D, et al. Behav Brain Res. 2003 Mar 18;140(1-2):131-9. doi: 10.1016/s0166-4328(02)00289-9. Behav Brain Res. 2003. PMID: 12644286

8

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.

Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Reglodi D, et al. Behav Brain Res. 2004 May 5;151(1-2):303-12. doi: 10.1016/j.bbr.2003.09.007. Behav Brain Res. 2004. PMID: 15084446

9

Development of the circadian melatonin rhythm and the effect of PACAP on melatonin release in the embryonic chicken pineal gland. An in vitro study.

Faluhelyi N, Reglodi D, Lengvári I, Csernus V. Faluhelyi N, et al. Among authors: reglodi d. Regul Pept. 2004 Dec 15;123(1-3):23-8. doi: 10.1016/j.regpep.2004.05.009. Regul Pept. 2004. PMID: 15518889

10

Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.

Reglodi D, Fábián Z, Tamás A, Lubics A, Szeberényi J, Alexy T, Tóth K, Márton Z, Borsiczky B, Rõth E, Szalontay L, Lengvári I. Reglodi D, et al. Regul Pept. 2004 Dec 15;123(1-3):51-9. doi: 10.1016/j.regpep.2004.05.012. Regul Pept. 2004. PMID: 15518893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters